Trade

Coral Laboratories share price

Balanced risk
  • 45%Low risk
  • 45%Moderate risk
  • 45%Balanced risk
  • 45%High risk
  • 45%Extreme risk
  • ₹604.00(0.53%)
    July 16, 2025 15:45:15 PM IST
    • NSE
    • BSE
  • Vol : 0.47K (NSE + BSE)
    Last 20 day avg : 1.11 K

Coral Laboratories is trading 0.53% upper at Rs 604.00 as compared to its last closing price. Coral Laboratories has been trading in the price range of 621.00 & 594.00. Coral Laboratories has given -21.24% in this year & 1.83% in the last 5 days. Coral Laboratories has TTM P/E ratio 10.37 as compared to the sector P/E of 23.03.The company posted a net profit of 2.83 Crores in its last quarter.Listed peers of Coral Laboratories include Alpa Laboratories (-0.91%), Bafna Pharmaceuticals (1.86%), Coral Laboratories (0.53%).The Mutual Fund holding in Coral Laboratories was at -% in . The MF holding has - from the last quarter. The FII holding in Coral Laboratories was at 0.23% in 30 Jun 2024. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Key Metrics

Updated on Jul 16, 2025, 11:59 AM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.25
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    1.05
    In line with historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    8.79
    Lower than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.76
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.02
    Higher than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
594.00
Highest
621.00
52 week range
Lowest
567.15
Highest
999.00
Coral Laboratories Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue fell during March quarter by 2.60% from Rs 28.89 crore to Rs 28.13 crore, year-on-year
    • financial-insightsThe company's profit declined by 51.15% year-on-year during the March quarter, dropping from Rs 5.79 crore to Rs 2.83 crore
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Coral Laboratories Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 615.77
  • R2
  • 634.33
  • R3
  • 654.72
Pivot595.38
  • S1
  • 576.82
  • S2
  • 556.43
  • S3
  • 537.87
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Coral Laboratories Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Alpa Laboratories
Bearish
103.20-0.91216.2111.191.28--
Bafna Pharmaceuticals
Bullish
89.641.86211.9551.172.51-16.54
Coral Laboratories
Neutral
604.000.53214.358.491.040.34-
Aarey Drugs & Pharmaceuticals
Bullish
67.39-1.99191.0838.591.44-1.43
Chemcrux Enterprises
Bearish
128.60-0.62191.6949.912.610.7638.40
Coral Laboratories Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Coral Laboratories is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 71.51%
    • InsightsFIIs are not invested in this company
    • InsightsMutual Funds are not invested in this company.
    Coral Laboratories Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-30Audited Results & Final Dividend
    2025-02-13Quarterly Results
    2024-11-14Quarterly Results
    2024-08-14Quarterly Results
    2024-08-09Others
    About the company Coral Laboratories
    • IndustryBiotechnology & Drugs
    • ISININE683E01017
    • BSE Code524506
    • NSE Code
    Coral Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical formulations. The Company is engaged in the manufacturing of generic - branded, nutraceuticals, over the counter (OTC), and herbal medicines. It offers dosage forms, which include tablets, capsules, liquid orals, injections (liquids and powder), ointment and creams, gels and lotions, and suppositories. Its product categories include nutraceutical, OTC, sterile and non-sterile. Its nutraceutical products include DAX 200, DAX 400 Drops, Zest drops, and Super Zestcal Tablets. Its OTC products include herbal range, skin care, medical devices, and effervescent range. Its sterile products include small volume liquid - injectables, lyophilized range - injectables, eye drops, and eardrops. Its non-sterile antibiotics/antibacterials, antifungals, gastro-intestinal drugs, anti-emetics, and muscle relaxants. The Company also exports its products to various countries.
    • Management Info
    • Sushma KadkadeChief Financial Officer, Director
    • Dhwani DesaiChief Compliance Officer, Company Secretary
    • Girish DhamejaWhole Time Director
    Coral Laboratories Share Price FAQs

    Coral Laboratories is trading at 604.00 as on Wed Jul 16 2025 10:15:15. This is 0.53% upper as compared to its previous closing price of 600.80.

    The market capitalization of Coral Laboratories is 214.35 Cr as on Wed Jul 16 2025 10:15:15.

    The 52 wk high for Coral Laboratories is 999.00 whereas the 52 wk low is 567.15

    Coral Laboratories can be analyzed on the following key metrics -

    • TTM P/E: 10.37
    • Sector P/E: 23.03
    • Dividend Yield: 0.25%
    • D/E ratio: 0.02

    Coral Laboratories reported a net profit of 24.16 Cr in 2025.

    Quick Links
    EQUITY QUICK LINKS
    Coral Laboratories QUICK LINKS
    FROM MARKETS
    RELATED LINKS
    Quarterly Results
    Business News/Market/Market Stats/   Coral Laboratories share price

    Wait for it…

    Log in to our website to save your bookmarks. It'll just take a moment.